Esha Randhawa
CIK: 0002047233
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Randhawa Esha
Randhawa Esha (SEC CIK 0002047233) files insider reports with the SEC as Director of BioRestorative Therapies, Inc. (BRTX) and Director of Virpax Pharmaceuticals, Inc. (VRPX).
Signal8 holds 2 ownership filings by Randhawa Esha, all Form 3s, filed between Dec 4, 2024 and Jul 30, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Randhawa Esha's filings is in MELVILLE, NY.
Other insiders filing for BioRestorative Therapies, Inc. (BRTX)
- Grasso Mika, Director
- Dhaliwal Jatinder, Director
- Field Katharyn, Director
- Silva Francisco, VP of Research and Development
- ALSTODT LANCE, President, CEO, COB
- Rosa David A, Director